Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

International Bioprinting Congress

Published: Monday, August 04, 2014
Last Updated: Monday, August 04, 2014
Bookmark and Share
Select Biosciences South East Asia is pleased to report on the success of the inaugural International Bioprinting Congress, which took place at the Biopolis, Singapore on the 24-25 July 2014.

The event featured Keynote Presentations from Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore and Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan.

The world’s leading experts presented their latest research covering all aspects of 3D Bioprinting to an international audience and then opened up the floor to lively panel discussions on each afternoon.

Topics discussed at the event included;

• Additive Manufacturing in Tissue Engineering : Current state-of-the-art on 3D Scaffolds
• 4D Bioprinting : biofabrication of rod-like and tubular tissue engineered constructs using programmable self-folding bioprinted biomaterials
• Peptide Inks : Bio-printing Self-Assembling Ultrashort Peptides to Build Nanofibrous Scaffolds for Regenerative Medicine Applications
• Microfluidic Cell Patterning Technique for Multicellular Dynamics Studies
• Regulatory Updates on Cellular and Tissue-based Products
• The Patent Landscape of Bioprinting
• The concepts of the challenges for the developments of Bioprinting and Biofabrication
• Organ Printing as an Information Technology : Towards Tissue and Organ Informatics
• 3D Bioprinting – Bioassembly Robots and Bioinks
• Magnetic 3D Bioprinting for High-Throughput Drug Screening
• Bioprinting interfaces for 2D and 3D Cell and Tissue models
• Multi-photon processing - a versatile technology platform for the development of standard bio-mimetic microenvironments for 3D cell culture
• A New Approach for 3D Tissue & Organ Fabrication Inspired From Orthopaedic Surgery
• 3D Bioprinting of Human Embryonic Stem Cells

The highly topical panel discussions covered the following areas;

Day 1 - Intellectual Property Landscape / Ethics Surrounding Bioprinting Human Parts and Tissue / Regulatory Path Forward

Day 2 - Easiest Tissue and Organ to Bioprint / Technology Advancement and Innovation for Bioprinting / How far are we realistically from the Clinic?

The audience also took advantage of a complimentary tour of the NTU Additive Manufacturing Centre, hosted by Professor Chua. Here the attendees were able to learn about the latest research at the facility which was enabled by the major investment Nanyang Technological University has undertaken.

The feedback for the event was exemplary with some of the attendees quoted as saying: 

“From a Co-Chair perspective, I am very pleased, the meeting was well organised and covered all aspects of the subject, from the scientific techniques through to intellectual property, moving forward in to the next advancements we can expect to see in the field. I am already looking forward to next year’s meeting.” Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore.

“Very good, gathered together many excellent speakers, I will definitely be involved next year.” Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan.

Outstanding science, engineering, intellectual property and regulatory discussions” Dr. Stuart Williams, Director, University of Louisville, USA.

“The most exciting conference I have ever attended. Very inspiring and very well organised.” Dr. Vladimir Mironov, Visiting Professor, Centre for Information Technology Renato Archer, Brazil.

“Very stimulating, I really enjoyed it. It was a pleasure to be here with the leaders in the field. Great debates about the future developments to come.” Dr. Weinmao (Will) Shu, Associate Professor, Heriot Watt University, UK.

“Very good, well done, great organisation, I would like to be involved next year.” Dr. Aleksandr Ovsianikov, Asst. Professor, Vienna University of Technology, Austria.

“Hot, important growing area and Select Biosciences is helping to lead the way. The panel discussions were especially innovative.” Dr. Mark DeCoster, Associate Professor, Biomedical Engineering, Louisiana Tech University, USA.

Next year’s event will also take place in Singapore, the dates are the 9-10 July, 2015. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Clinical Applications of Stem Cells, 26-27 February, 2015, Singapore.
The Singapore Bioimaging Consortium and Select Biosciences South East Asia are pleased to report on the success of The Clinical Applications of Stem Cells, which took place at The Academia, Singapore General Hospital Campus, Singapore on the 26-27 February 2015.
Monday, March 16, 2015
Scientific News
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Newfound Strength in Regenerative Medicine
A promising new approach uses direct mechanical stimulation to repair severely damaged skeletal muscles.
Mapping out Cell Conversion
Researchers develop algorithm that takes the field of cell reprogramming forward.
Donor's Genotype Controls the Differentiation of IPS Cells
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study by the University of Helsinki and the National Institute for Health and Welfare, Finland. However, the genotype of the donor strongly influences the differentiation of the stem cell.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!